CBPO  China Biologic Products Inc.

Exchange

NASDAQ

Sector

Health Care

Industry

Biotechnology: Biological Products (No Diagnostic Substances)

Market Cap.

3.12B

Vuru Grade

72.45/100

Current Price

$117.39
+1.22 (+1.05%)

Growth Price

$39.71
Overvalued by 66.17%

Stability Price

$22.12
Overvalued by 81.16%

Company Metrics

  • P/E 35.12
  • P/S 9.91
  • P/B 7.44
  • EPS 3.34
  • Cash ROIC 27.80%
  • Cash Ratio 2.02
  • Dividend 0 / 0%
  • Avg. Vol. 256,508.00
  • Shares 26.58M
  • Market Cap. 3.12B

Company Description

China Biologic Products, Inc., a biopharmaceutical company, engages in the research, development, production, and manufacture of plasma-based pharmaceutical products in the People's Republic of China. It offers Human Albumin for the treatment of shock caused by blood loss trauma or burn; raised intracranial pressure caused by hydrocephalus or trauma; oedema or ascites caused by hepatocirrhosis and... more


Download 10 Years of Financial Statements:
Income Statement   Balance Sheet   Cash Flow

News

China Biologic Products, Inc. (NASDAQ:CBPO) Quarterly EPS From Continuing ...
Markets Daily - 52 minutes ago
For the year ended 2016-03-31 China Biologic Products, Inc. (NASDAQ:CBPO) basic consolidated EPS reported was $4.4574.
Ativo Capital Management Lowers stake in China Biologic Products Inc (CBPO) - Market Digest
Promising stocks in today's market: China Biologic Products, Inc. (NASDAQ:CBPO)
The News Journal - May 27, 2016
Based on the aggregate value of the company over its current share price and the total amount of outstanding stocks, the market cap of China Biologic Products, Inc. is presently reeling at 3059.92. Acting as the blue chip in today's trade, China ...
China Biologic Products Inc. Q1 Profit Advances 22%
Nasdaq - May 4, 2016
released earnings for its first quarter that gained ground compared to the same period last year. The company said its bottom line advanced to $30.44 million, or $1.09 per share.
China Biologic Products Inc (CBPO) Announces Earnings Results - Web Breaking News
China Biologic Products Inc (CBPO) Releases Earnings Results, Beats ... - Market Digest
Recently Changed Price Targets On China Biologic Products, Inc. (NASDAQ:CBPO)
Risers & Fallers - May 24, 2016
A number of investment brokers have recently updated their price targets on shares of China Biologic Products, Inc. (NASDAQ:CBPO).
Matthews International Capital Management Lowers stake in China Biologic ... - Market Digest
How Many China Biologic Products Inc (NASDAQ:CBPO)'s Analysts Are Bearish? - The Post
China Biologic Products: An Alternative To The U.S Sector
Seeking Alpha - May 17, 2016
China Biologic Products Inc. is a mid cap biotech focused on plasma based technology. The firm manufactures twenty products for use in emergency rooms and in the treatment of immuno-deficiency related illnesses.
China Biologic Products, Inc. (NASDAQ:CBPO) Reports Basic Consolidated EPS At ... - Markets Daily
China Biologic Products Inc (CBPO) Downgraded by Zacks Investment Research to ...
NewsWay 21 - May 9, 2016
China Biologic Products Inc logo Zacks Investment Research lowered shares of China Biologic Products Inc (NASDAQ:CBPO) from a hold rating to a sell rating in a research note issued to investors on Friday morning, Analyst Ratings Network.
China Biologic Products, Inc. (NASDAQ:CBPO) - Broker Update - Risers & Fallers
China Biologic Products Inc (CBPO) Downgraded by Zacks Investment Research to Sell
South Florida Hedge Fund Managers - Apr 5, 2016
China Biologic Products logo China Biologic Products Inc (NASDAQ:CBPO) was downgraded by Zacks Investment Research from a “hold” rating to a “sell” rating in a research note issued to investors on Monday, MarketBeat Ratings reports.
Analyst Review: China Biologic Products, Inc. (NASDAQ:CBPO)
Risers & Fallers - May 27, 2016
A number of investment brokers have recently updated their price targets on shares of China Biologic Products, Inc. (NASDAQ:CBPO).
China Biologic Products, Inc. (NASDAQ:CBPO) Closes At $115.48
Markets Daily - May 25, 2016
The technical analysis of China Biologic Products, Inc. (NASDAQ:CBPO) stock highlights the stock is $-4.62 points away -3.86% from its 50-day MA of $119.71.
China Biologic Products Inc (CBPO) Short Interest Update
South Florida Hedge Fund Managers - Apr 1, 2016
China Biologic Products logo China Biologic Products Inc (NASDAQ:CBPO) was the target of a large decrease in short interest in March.